AxoGen, Inc. (AXGN) Ownership
AXGN ownership summary
as of October 18, 2026- Institutions
- 97.7% of shares outstanding
- Insiders
- 1.98% of shares outstanding
- Shares outstanding
- 58.7M
- Float
- 49.1M shares available to trade
- Short interest
- 9.14% 4.7M shares short
- Days to cover
- 3.70 short interest up 15.8% vs prior month
- Institutions 97.69%
- Insiders 1.98%
- Other investors 0.33%
AXGN top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | BlackRock Inc | 7.53% | 4.4M | $153.0M | +548,357 (+14.2%) | June 30, 2026 |
| 2 | First Light Asset Management, LLC | 4.68% | 2.7M | $95.1M | −1.3M (−31.3%) | June 30, 2026 |
| 3 | Morgan Stanley - Brokerage Accounts | 4.68% | 2.7M | $95.1M | −375,058 (−12.0%) | June 30, 2026 |
| 4 | Vanguard Capital Management, LLC | 3.85% | 2.3M | $78.2M | −33,615 (−1.5%) | June 30, 2026 |
| 5 | Assenagon Asset Management SA | 3.56% | 2.1M | $72.3M | +706,037 (+51.1%) | June 30, 2026 |
| 6 | Polar Capital Holdings PLC | 2.56% | 1.5M | $52.0M | — | June 30, 2026 |
| 7 | Artemis Investment Management LLP | 2.38% | 1.4M | $48.4M | +1.0M (+299.2%) | June 30, 2026 |
| 8 | Wellington Management Company LLP | 2.37% | 1.4M | $48.2M | +427,089 (+44.3%) | June 30, 2026 |
| 9 | Geode Capital Management, LLC | 2.34% | 1.4M | $47.6M | +155,099 (+12.7%) | June 30, 2026 |
| 10 | Citadel Advisors Llc | 2.32% | 1.4M | $47.1M | +1.1M (+455.3%) | June 30, 2026 |
| 11 | Wasatch Advisors LP | 2.21% | 1.3M | $44.9M | −561,401 (−30.2%) | June 30, 2026 |
| 12 | The Goldman Sachs Group Inc | 2.15% | 1.3M | $43.7M | +678,556 (+116.4%) | June 30, 2026 |
| 13 | State Street Corp | 2.13% | 1.2M | $43.2M | +100,318 (+8.7%) | June 30, 2026 |
| 14 | FMR Inc | 2.08% | 1.2M | $42.3M | −91,156 (−6.9%) | June 30, 2026 |
| 15 | Hood River Capital Management LLC | 1.82% | 1.1M | $36.9M | +1.1M (0.0%) | June 30, 2026 |
| 16 | T. Rowe Price Associates, Inc. | 1.74% | 1.0M | $35.2M | +967,257 (+1,904.6%) | June 30, 2026 |
| 17 | RTW INVESTMENTS, LLC | 1.72% | 1.0M | $35.0M | +1.0M (0.0%) | June 30, 2026 |
| 18 | Next Century Growth Investors LLC | 1.49% | 873K | $30.2M | +6,583 (+0.8%) | June 30, 2026 |
| 19 | UBS Group AG | 1.43% | 836K | $28.9M | +721,989 (+632.1%) | June 30, 2026 |
| 20 | Armistice Capital, LLC | 1.32% | 775K | $26.8M | −161,000 (−17.2%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 13 holders added 8.6M shares and 6 cut 2.5M.
AXGN top mutual fund and ETF holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Vanguard MStar Total Stk Mkt Idx Invest | 2.73% | 1.6M | $55.4M | −2,260 (−0.1%) | August 31, 2026 |
| 2 | Polar Capital Healthcare Opports Inc | 2.55% | 1.5M | $51.8M | — | August 31, 2026 |
| 3 | iShares Russell 2000 ETF | 2.35% | 1.4M | $47.8M | −15,936 (−1.1%) | September 30, 2026 |
| 4 | Artemis US Smaller Companies I Acc GBP | 1.39% | 818K | $28.3M | — | June 30, 2026 |
| 5 | Hood River Small-Cap Growth Instl | 1.17% | 688K | $23.8M | +687,859 (0.0%) | June 30, 2026 |
| 6 | T. Rowe Price New Horizons | 1.09% | 641K | $22.2M | — | September 30, 2026 |
| 7 | Baron Discovery Institutional | 1.04% | 612K | $21.2M | +79,194 (+14.9%) | September 30, 2026 |
| 8 | Fidelity Small Cap Index | 0.98% | 575K | $19.9M | +5,076 (+0.9%) | July 31, 2026 |
| 9 | Fidelity Stock Selector Small Cap | 0.90% | 526K | $18.2M | — | July 31, 2026 |
| 10 | iShares Russell 2000 Growth ETF | 0.84% | 495K | $17.1M | −626 (−0.1%) | September 30, 2026 |
| 11 | Oberweis Micro-Cap | 0.64% | 374K | $13.0M | +46,400 (+14.1%) | June 30, 2026 |
| 12 | Wasatch Small Cap Growth Investor | 0.53% | 310K | $10.7M | −161,760 (−34.3%) | June 30, 2026 |
| 13 | Vanguard Russell 2000 ETF | 0.53% | 309K | $10.7M | +6,760 (+2.2%) | September 30, 2026 |
| 14 | Schwab US Small-Cap ETF™ | 0.53% | 309K | $10.7M | +207 (+0.1%) | September 30, 2026 |
| 15 | Fidelity Series Small Cap Opps | 0.51% | 302K | $10.5M | −8,500 (−2.7%) | July 31, 2026 |
| 16 | Fidelity Enhanced Small Cap Core ETF | 0.51% | 302K | $10.4M | +630 (+0.2%) | September 30, 2026 |
| 17 | Wasatch Micro Cap | 0.50% | 294K | $10.2M | −124,317 (−29.7%) | June 30, 2026 |
| 18 | Alger Small Cap Focus I | 0.50% | 291K | $10.1M | +55,905 (+23.8%) | July 31, 2026 |
| 19 | iShares US Medical Devices ETF | 0.49% | 288K | $10.0M | +5,040 (+1.8%) | September 30, 2026 |
| 20 | Meridian Growth Legacy | 0.49% | 285K | $9.9M | −19,087 (−6.3%) | June 30, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
AXGN insider transactions
latest 20| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-16 | Erick Wayne Devinney | Sell | $32.84 | 5,221 | $171,458 |
| 2025-12-16 | Amy Mcbride Wendell | Sell | $29.31 | 43,684 | $1.3M |
| 2025-12-16 | Kathy Johnson Weiler | Sell | $29.55 | 46,653 | $1.4M |
| 2025-12-15 | Lindsey Marie Hartley | Sell | $29.86 | 14,812 | $442,286 |
| 2025-12-09 | Erick Wayne Devinney | Sell | $31.21 | 19,517 | $609,126 |
| 2025-12-09 | John Johnson | Sell | $29.98 | 21,686 | $650,146 |
| 2025-12-09 | Joseph A Tyndall | Sell | $30.98 | 25,108 | $777,846 |
| 2025-12-09 | Marc A Began | Sell | $31.21 | 9,278 | $289,566 |
| 2025-12-09 | Michael D Dale | Sell | $31.21 | 61,463 | $1.9M |
| 2025-12-09 | Paul Thomas | Sell | $29.61 | 21,399 | $633,624 |
| 2025-12-08 | John Johnson | Sell | $31.24 | 23,693 | $740,169 |
| 2025-12-08 | Lindsey Marie Hartley | Sell | $31.56 | 14,387 | $454,054 |
| 2025-11-11 | William P Mr. Burke | Sell | $24.02 | 3,591 | $86,256 |
| 2025-11-10 | William P Mr. Burke | Sell | $24.01 | 19,227 | $461,640 |
| 2025-11-06 | William P Mr. Burke | Sell | $24.01 | 5,347 | $128,381 |
| 2025-11-05 | William P Mr. Burke | Sell | $24.05 | 11,431 | $274,916 |
| 2025-10-30 | William P Mr. Burke | Sell | $23.00 | 18,248 | $419,704 |
| 2025-10-29 | William P Mr. Burke | Sell | $20.55 | 40,235 | $826,829 |
| 2025-10-22 | William P Mr. Burke | Sell | $18.02 | 1,457 | $26,255 |
| 2025-10-06 | William P Mr. Burke | Sell | $18.00 | 736 | $13,248 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
AXGN shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns AXGN
Institutional investors own 97.7% of AxoGen's shares and insiders 1.98%. The largest holder is BlackRock Inc with 7.53% of the shares (4.4M), as of June 30, 2026. Among the top 20 institutions, 13 added shares and 6 reduced their stake in the latest filings. Short interest is 9.14% of the float, or 3.70 days of average trading volume. The share count rose 108.4% since 2014.
Related: AXGN analyst forecast, AXGN key metrics. See the AXGN stock overview for the latest quote and news.
AXGN ownership FAQ
Who owns the most AxoGen stock?
The largest shareholders of AxoGen are BlackRock Inc (7.53%), First Light Asset Management, LLC (4.68%), Morgan Stanley - Brokerage Accounts (4.68%), Vanguard Capital Management, LLC (3.85%), Assenagon Asset Management SA (3.56%).
What percentage of AxoGen is owned by institutions?
Institutions hold 97.7% of AxoGen's shares outstanding; insiders hold 1.98%.
Which funds own AxoGen?
The largest fund holders of AxoGen are Vanguard MStar Total Stk Mkt Idx Invest (2.73%), Polar Capital Healthcare Opports Inc (2.55%), iShares Russell 2000 ETF (2.35%), Artemis US Smaller Companies I Acc GBP (1.39%), Hood River Small-Cap Growth Instl (1.17%).
What is AxoGen's short interest?
4.7M shares of AxoGen were sold short, 9.14% of the float; at the average daily volume it would take 3.70 days to cover.
Are insiders buying or selling AxoGen?
Of the latest 20 reported insider transactions in AxoGen (since October 6, 2025), 0 were purchases and 20 were sales.
How many shares of AxoGen are outstanding?
AxoGen has 58.7M shares outstanding, of which 49.1M are in the public float.